We’re covering the international race for a Covid-19 vaccine — and how Brazil fits in. What is happening to Latin American exports amid the pandemic. And new regulations for investors.
Promising Covid-19 vaccines being tested in Brazil
Out of 197 coronavirus vaccine studies being conducted worldwide, three seem to be head and shoulders ahead, having moved to the third and final stage of trials. Two of these are being tested in Brazil.
- A vaccine developed by British-Swedish lab AstraZeneca and the University of Oxford has caused an immune response against Covid-19, according to new research involving roughly 1,000 patients. The vaccine is currently being tested in a group of volunteers in São Paulo, in a trial organized by the Federal University of São Paulo.
- The breakthrough development came on the same day as another potential vaccine developed by Chinese lab Sinovac Biotech arrived in São Paulo. Tests will be initially administered to health workers in five states — and then in 9,000 volunteers.
- A vaccine by U.S. biotech firm Moderna is also heading into phase 3 trials.
Why it matters. At this point, lockdowns are out of the question for Brazil. Infections and deaths have plateaued at high levels —...